Torrent Pharmaceuticals has informed that the Company and Glenmark Pharmaceuticals have signed licensing agreement for co-marketing of Remogliflozin Etabonate in India. A Press release, containing the transaction details, which is being submitted to the media is enclosed herewith for information and record.
The above information is a part of company’s filings submitted to BSE.